Teva Pharmaceutical Industries Statistics
NYSE: TEVAHealth CareBiotechnology: Pharmaceutical PreparationsUSD
39.18+0.05 (+0.13%)
At close: Oct 7, 4:00 PM ET · Delayed 15 min
Teva Pharmaceutical Industries by the numbers
Teva Pharmaceutical Industries has a market capitalization of $45.70 billion based on 1.17B shares outstanding. Its trailing P/E ratio is 65.3, above the 6-company peer median of 29.5, and its forward P/E is 12.7. The stock trades 5.1% above its 50-day average and 16.0% above its 200-day average.
Average daily trading volume is 5.32M shares, or about $208.4 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
TEVA valuation vs. peer median
| Metric | TEVA | Peer median | Difference |
|---|---|---|---|
| Market cap | $45.70B | $29.80B | +53% |
| P/E (TTM) | 65.3 | 29.5 | +121% |
| Forward P/E | 12.7 | 18.0 | -30% |
| Avg. volume | 5.32M | 2.85M | +87% |
Peer median across 8 companies: ONC, RPRX, TAK, ALNY, ZTS, ROIV, UTHR, GMAB.
Valuation
- Market cap
- $45.70B
- P/E (TTM)
- 65.30
- Forward P/E
- 12.68
- Price / sales (latest FY)
- 2.65
- EPS (TTM)
- $0.60
- Shares outstanding
- 1.17B
Price and trading
- Previous close
- 39.13
- Open
- 38.93
- Day range
- 38.65 – 39.39
- 52-week range
- 18.83 – 40.79
- 52-week change
- +95.22%
- Beta
- —
- Volume
- 3.46M
- Average volume
- 5.32M
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 3, 2026
Additional statistics
- Market Cap
- 45.70B
- Pe
- 65.30
- Forward Pe
- 12.68
- Eps
- 0.60
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 40.79
- Week52 Low
- 18.83
- Avg Volume
- 5.32M
- Shares Outstanding
- 1.17B
- Ma50
- 37.27
- Ma200
- 33.77
- Earnings Date
- Nov 3, 2026
- Pct From52w High
- -3.95%
- Pct From52w Low
- 108.07%